Kirkland's (KIRK) Tops Q4 EPS by 32c

Kirkland's (NASDAQ: KIRK) reported Q4 EPS of $0.78, $0.32 better than the analyst estimate of $0.46. Revenue for the quarter came in at $165.9 million versus the consensus estimate of $167 million.

For earnings history and earnings-related data on Kirkland's (KIRK) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c